These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23566440)

  • 1. Improved amino acid, bioenergetic metabolite and neurotransmitter profiles following human amnion epithelial cell transplant in intermediate maple syrup urine disease mice.
    Skvorak KJ; Dorko K; Marongiu F; Tahan V; Hansel MC; Gramignoli R; Arning E; Bottiglieri T; Gibson KM; Strom SC
    Mol Genet Metab; 2013 Jun; 109(2):132-8. PubMed ID: 23566440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental stem cell correction of murine intermediate maple syrup urine disease.
    Skvorak KJ; Dorko K; Marongiu F; Tahan V; Hansel MC; Gramignoli R; Gibson KM; Strom SC
    Hepatology; 2013 Mar; 57(3):1017-23. PubMed ID: 23175463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD).
    Skvorak KJ; Hager EJ; Arning E; Bottiglieri T; Paul HS; Strom SC; Homanics GE; Sun Q; Jansen EE; Jakobs C; Zinnanti WJ; Gibson KM
    Biochim Biophys Acta; 2009 Oct; 1792(10):1004-10. PubMed ID: 19699299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease.
    Skvorak KJ; Paul HS; Dorko K; Marongiu F; Ellis E; Chace D; Ferguson C; Gibson KM; Homanics GE; Strom SC
    Mol Ther; 2009 Jul; 17(7):1266-73. PubMed ID: 19436271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle-directed AAV gene therapy rescues the maple syrup urine disease phenotype in a mouse model.
    Greig JA; Jennis M; Dandekar A; Chorazeczewski JK; Smith MK; Ashley SN; Yan H; Wilson JM
    Mol Genet Metab; 2021; 134(1-2):139-146. PubMed ID: 34454844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice.
    Zimmerman HA; Olson KC; Chen G; Lynch CJ
    Mol Genet Metab; 2013 Aug; 109(4):345-53. PubMed ID: 23800641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical perspective on the use of human amniotic epithelial cells to treat congenital metabolic diseases with a focus on maple syrup urine disease.
    Takano C; Grubbs BH; Ishige M; Ogawa E; Morioka I; Hayakawa S; Miki T
    Stem Cells Transl Med; 2021 Jun; 10(6):829-835. PubMed ID: 33547875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
    Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
    Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of murine models of classic and intermediate maple syrup urine disease.
    Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS
    BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease.
    Vogel KR; Arning E; Wasek BL; McPherson S; Bottiglieri T; Gibson KM
    Orphanet J Rare Dis; 2014 May; 9():73. PubMed ID: 24886632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
    Strauss KA; Carson VJ; Soltys K; Young ME; Bowser LE; Puffenberger EG; Brigatti KW; Williams KB; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Chopko S; Hailey J; Muelly ER; Shellmer DA; Radcliff Z; Rodrigues A; Loeven K; Heaps AD; Mazariegos GV; Morton DH
    Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity.
    Korein J; Sansaricq C; Kalmijn M; Honig J; Lange B
    Int J Neurosci; 1994 Nov; 79(1-2):21-45. PubMed ID: 7744549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living related versus deceased donor liver transplantation for maple syrup urine disease.
    Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
    Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibits Branched Chain Amino Acid (BCAA) derived ketoacidosis and promotes metabolic homeostasis in MSUD.
    S Sonnet D; N O'Leary M; A Gutierrez M; M Nguyen S; Mateen S; Hsu Y; P Mitchell K; J Lopez A; Vockley J; K Kennedy B; Ramanathan A
    Sci Rep; 2016 Jul; 6():28775. PubMed ID: 27373929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
    Xu J; Jakher Y; Ahrens-Nicklas RC
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical maple syrup urine disease and brain development: principles of management and formula design.
    Strauss KA; Wardley B; Robinson D; Hendrickson C; Rider NL; Puffenberger EG; Shellmer D; Moser AB; Morton DH
    Mol Genet Metab; 2010 Apr; 99(4):333-45. PubMed ID: 20061171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Cryogenic Storage on Human Amnion Epithelial Cells.
    Srinivasan RC; Strom SC; Gramignoli R
    Cells; 2020 Jul; 9(7):. PubMed ID: 32679793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids.
    Wendel U; Becker K; Przyrembel H; Bulla M; Manegold C; Mench-Hoinowski A; Langenbeck U
    Eur J Pediatr; 1980 Jun; 134(1):57-63. PubMed ID: 7408911
    [No Abstract]   [Full Text] [Related]  

  • 20. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration.
    Hmiel SP; Martin RA; Landt M; Levy FH; Grange DK
    Pediatr Crit Care Med; 2004 May; 5(3):278-81. PubMed ID: 15115568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.